agbt

Genetic Future

Category archives for agbt

Dan Koboldt has a very nice recap of the various sequencing technologies presented at last week’s Advances in Genome Biology and Technology meeting. I totally agree with his central point: Something had been bothering me about the sequencing-company presentations this year, and I finally realized what it was. During AGBT 2009, every player was gunning…

The main theme of this year’s Advances in Genome Biology and Technology meeting should come as no surprise to regular readers: sequencing. Generating as many bases of DNA sequence as quickly, cheaply and accurately as possible is the goal of the moment, and the number of companies jostling to achieve that goal is growing rapidly.…

Stephen Turner from Pacific Biosciences gave a dramatic presentation this afternoon launching PacBio’s new third-generation sequencing instrument. The room was packed for the seminar, with a palpable buzz, and Turner’s presentation was preceded by a theatrical introduction from PacBio CEO Hugh Martin.  The crescendo of Turner’s presentation was the unveiling of a video showing the…

Belated news from AGBT

I’ve been remiss in blogging from the Advances in Genome Biology and Technology meeting here in Marco Island, Florida, primarily due to some panic-stricken last-minute changes to the slides for my own presentation last night. Fortunately the conference has been extremely well-covered by others: Sanger colleague Luke Jostins has blog posts up summarising day 1…

I’ll be at the Advances in Genome Biology and Technology meeting in Marco Island, Florida for the next week, soaking up sun and genomics, keeping my eye out for the anticipated major announcements from sequencing companies and researchers, and quietly panicking about my presentation on Thursday. You’ll hear more about the meeting from me and…

The big news from the JP Morgan investment conference today is the announcement of a brand new shiny sequencing machine from Illumina, the HiSeq 2000. The new machine boasts an impressive set of statistics, and looks likely to gradually replace Illumina’s GAIIx as the workhorse of most modern sequencing facilities. So, how excited should we…

I doubt anyone’s noticed, but I recently rearranged my “Blogs I Read” menu to give appropriate prominence to three fellow genomics bloggers: Anthony Fejes, Dan Koboldt and David Dooling. If you’re interested in the cutting edge of modern genomics you should definitely be reading these guys; all three are researchers working on hard problems in…

I discussed the second-generation sequencing company Complete Genomics a couple of weeks ago (see here and here). These guys are unique in that they offer their technology only as a service, rather than the usual business model of selling platforms to genomics facilities, and a highly restricted service at that: Complete has stated fairly categorically…

I wrote last week about the dramatic presentation here at  AGBT by Clifford Reid, CEO of new DNA sequencing company Complete Genomics. Reid made grand promises – entire human genome sequencing for $5000 available this year, and the sequencing of a million complete human genomes within the next five years – and presented some impressive…

I’ll be uploading a few of what I saw as the highlights from the AGBT meeting over the next week or so, as I go over my notes – you can also browse over Anthony Fejes‘ blog for live-blogging of many of the sessions. In no particular order, here are some of the tid-bits gleaned…